Literature DB >> 29607872

A Case of Primary Mediastinal Leiomyosarcoma in Which Long-Term Survival Was Achieved.

Yoshihito Iijima1, Hirohiko Akiyama1, Yuki Nakajima1, Hiroyasu Kinoshita1, Tomomi Hirata1.   

Abstract

INTRODUCTION: Primary leiomyosarcomas (LMS) of the mediastinum are extremely rare malignant mesenchymal tumors developing from soft tissues or great vessels. We present a case of a primary leiomyosarcoma of the middle mediastinum in which long-term survival was achieved. CASE REPORT: A 77-year-old man presented to us for examination with an extrapleural sign in his upper mediastinum on chest X-ray. Computed tomography (CT) revealed a well-circumscribed mass in the middle mediastinum. Thoracoscopic resection of the mediastinal tumor and immunohistological findings, which were positive for smooth muscle actin (SMA), HHF-35, vimentin, and desmin confirmed primary leiomyosarcoma. It recurred twice with solid right pulmonary metastases, which were resected. He was followed-up for a total of 9 years and 6 months from the first surgery with no signs of recurrence after his last surgery.
CONCLUSION: Surgical resection of both the primary tumor and pulmonary metastases remains the mainstay of treatment of primary leiomyosarcomas.

Entities:  

Keywords:  leiomyosarcoma; mediastinal tumor; pulmonary metastasis

Mesh:

Year:  2018        PMID: 29607872      PMCID: PMC7184031          DOI: 10.5761/atcs.cr.18-00041

Source DB:  PubMed          Journal:  Ann Thorac Cardiovasc Surg        ISSN: 1341-1098            Impact factor:   1.520


  16 in total

1.  Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial.

Authors:  Winette T A van der Graaf; Jean-Yves Blay; Sant P Chawla; Dong-Wan Kim; Binh Bui-Nguyen; Paolo G Casali; Patrick Schöffski; Massimo Aglietta; Arthur P Staddon; Yasuo Beppu; Axel Le Cesne; Hans Gelderblom; Ian R Judson; Nobuhito Araki; Monia Ouali; Sandrine Marreaud; Rachel Hodge; Mohammed R Dewji; Corneel Coens; George D Demetri; Christopher D Fletcher; Angelo Paolo Dei Tos; Peter Hohenberger
Journal:  Lancet       Date:  2012-05-16       Impact factor: 79.321

2.  A systematic meta-analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft-tissue sarcoma.

Authors:  Nabeel Pervaiz; Nigel Colterjohn; Forough Farrokhyar; Richard Tozer; Alvaro Figueredo; Michelle Ghert
Journal:  Cancer       Date:  2008-08-01       Impact factor: 6.860

3.  Primary leiomyosarcoma of the anterior mediastinum encasing the aortic arch, left common carotid and left subclavian arteries.

Authors:  Takashi Iwata; Takuya Miura; Kazushige Inoue; Shoji Hanada; Hidetoshi Inoue; Yuji Miyamoto
Journal:  Ann Thorac Cardiovasc Surg       Date:  2011-10-28       Impact factor: 1.520

Review 4.  Mediastinal masses.

Authors:  N A Silverman; D C Sabiston
Journal:  Surg Clin North Am       Date:  1980-08       Impact factor: 2.741

5.  Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trial.

Authors:  Patrick Schöffski; Sant Chawla; Robert G Maki; Antoine Italiano; Hans Gelderblom; Edwin Choy; Giovanni Grignani; Veridiana Camargo; Sebastian Bauer; Sun Young Rha; Jean-Yves Blay; Peter Hohenberger; David D'Adamo; Matthew Guo; Bartosz Chmielowski; Axel Le Cesne; George D Demetri; Shreyaskumar R Patel
Journal:  Lancet       Date:  2016-02-10       Impact factor: 79.321

6.  Statistics of soft-tissue sarcoma in Japan: Report from the Bone and Soft Tissue Tumor Registry in Japan.

Authors:  Koichi Ogura; Takahiro Higashi; Akira Kawai
Journal:  J Orthop Sci       Date:  2017-07       Impact factor: 1.601

Review 7.  Doxorubicin-based chemotherapy for the palliative treatment of adult patients with locally advanced or metastatic soft tissue sarcoma.

Authors:  V H C Bramwell; D Anderson; M L Charette
Journal:  Cochrane Database Syst Rev       Date:  2003

Review 8.  Malignant smooth muscle tumors presenting as mediastinal soft tissue masses. A clinicopathologic study of 10 cases.

Authors:  C A Moran; S Suster; G Perino; M Kaneko; M N Koss
Journal:  Cancer       Date:  1994-10-15       Impact factor: 6.860

9.  Leiomyosarcoma arising from soft tissue tumor of the mediastinum.

Authors:  Hiroshi Hirano; Tomohiko Kizaki; Terumasa Sashikata; Tamaki Maeda; Yasuyoshi Yoshii
Journal:  Med Electron Microsc       Date:  2003-03

10.  The clinical outcome of pazopanib treatment in Japanese patients with relapsed soft tissue sarcoma: A Japanese Musculoskeletal Oncology Group (JMOG) study.

Authors:  Tomoki Nakamura; Akihiko Matsumine; Akira Kawai; Nobuhito Araki; Takahiro Goto; Tsukasa Yonemoto; Hideshi Sugiura; Yoshihiro Nishida; Hiroaki Hiraga; Kanya Honoki; Taketoshi Yasuda; Shogen Boku; Akihiro Sudo; Takafumi Ueda
Journal:  Cancer       Date:  2016-03-11       Impact factor: 6.860

View more
  1 in total

1.  Cardiopulmonary bypass does not consequentially contribute to postoperative distant metastasis of giant refractory thoracic tumors: A retrospective study with long-term follow-up.

Authors:  Lei Chen; Xuejuan Zhu; Rongying Zhu; Xing Jin; Liping Tan; Yongbing Chen
Journal:  Thorac Cancer       Date:  2021-09-16       Impact factor: 3.500

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.